2 completed, 1 active not recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Idiopathic Interstitial Pneumonias: new trials by email Literature Review of Idiopathic Interstitial Pneumonias trials Research Report on Idiopathic Interstitial Pneumonias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atezolizumab for Idiopathic Pulmonary Fibrosis Atezolizumab - Idiopathic Pulmonary Fibrosis | Phase 1 | Active not recruiting | Cedars-Sinai Medical Center | 24 | 2023-02-15 | 2026-02-20 |
| The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. SC1011 - Diopathic Pulmonary Fibrosis, Pulmonary Fibrosis | Phase 1 | Completed | Guangzhou JOYO Pharma Co., Ltd | 55 | 2021-06-03 | 2024-11-19 |
| Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease Bone marrow mesenchymal stem cells, Placebo - Idiopathic Interstitial Pneumonia, Interstitial Lung Disease | Phase 1 / Phase 2 | Completed | Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | 20 | 2013-02-01 | 2018-01-09 |
Idiopathic Pulmonary Fibrosis (3) · Pulmonary Fibrosis (2) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Respiratory Tract Diseases (1)
Fibrosis (2) · Lung Diseases (2) · Lung Diseases, Interstitial (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2) · Pulmonary Fibrosis (1)
atezolizumab (1)
Cedars-Sinai Medical Center (1) · Federal Research Clinical Center of Federal Medical & Biological Agency, Russia (1) · Guangzhou JOYO Pharma Co., Ltd (1)
China (1) · Russia (1) · United States (1)